# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2399030 | A | Cmax in CD1 mouse at 250 mg/kg | Mus musculus | 4 | ALA2396517 | organism-based format | Scientific Literature | |
2. | ALA2399031 | B | Inhibition of MSK2 (unknown origin) | Homo sapiens | 1 | ALA2396517 | single protein format | Scientific Literature | |
3. | ALA2399032 | A | Cmax in CD1 mouse at 5 mg/kg | Mus musculus | 4 | ALA2396517 | organism-based format | Scientific Literature | |
4. | ALA2399037 | B | Inhibition of PIK3C2A (unknown origin) | Homo sapiens | 2 | ALA2396517 | single protein format | Scientific Literature | |
5. | ALA2399038 | B | Inhibition of PIK3C2B (unknown origin) | Homo sapiens | 2 | ALA2396517 | single protein format | Scientific Literature | |
6. | ALA2399039 | B | Inhibition of STK17A (unknown origin) | Homo sapiens | 2 | ALA2396517 | single protein format | Scientific Literature | |
7. | ALA2399041 | F | Antiviral activity against Human coxsackievirus B3 assessed as protection against virus-induced cytopathic effect by cell-based assay | Coxsackievirus B3 | 4 | ALA2396517 | organism-based format | Scientific Literature | |
8. | ALA2399042 | F | Antiviral activity against Human coxsackievirus B4 assessed as protection against virus-induced cytopathic effect by cell-based assay | Coxsackievirus B4 | 4 | ALA2396517 | organism-based format | Scientific Literature | |
9. | ALA2399043 | F | Antiviral activity against Poliovirus assessed as protection against virus-induced cytopathic effect by cell-based assay | Poliovirus | 4 | ALA2396517 | cell-based format | Scientific Literature | |
10. | ALA2399044 | F | Antiviral activity against Echovirus assessed as protection against virus-induced cytopathic effect by cell-based assay | Echovirus | 4 | ALA2396517 | organism-based format | Scientific Literature | |
11. | ALA2399045 | F | Antiviral activity against Human rhinovirus C15 assessed as inhibition of viral RNA replication by luciferase reporter replicon assay | Human rhinovirus sp. | 4 | ALA2396517 | organism-based format | Scientific Literature | |
12. | ALA2399046 | F | Antiviral activity against Human rhinovirus A16 assessed as inhibition of viral RNA replication by luciferase reporter replicon assay | rhinovirus A16 | 4 | ALA2396517 | organism-based format | Scientific Literature | |
13. | ALA2399047 | F | Antiviral activity against Human rhinovirus B14 assessed as inhibition of viral RNA replication by luciferase reporter replicon assay | rhinovirus B14 | 4 | ALA2396517 | organism-based format | Scientific Literature | |
14. | ALA2399053 | B | Inhibition of PI4K3alpha (unknown origin) | Homo sapiens | 10 | ALA2396517 | assay format | Scientific Literature | |
15. | ALA2399054 | B | Inhibition of PI4K3beta (unknown origin) | Homo sapiens | 10 | ALA2396517 | single protein format | Scientific Literature | |
16. | ALA2399055 | A | Inhibition of CYP3A4 (unknown origin) | Homo sapiens | 15 | ALA2396517 | single protein format | Scientific Literature | |
17. | ALA2399057 | A | Metabolic stability in human liver microsomes relative to hepatic blood flow | Homo sapiens | 15 | ALA2396517 | microsome format | Scientific Literature | |
18. | ALA2399058 | A | Permeability across apical to basolateral side in human Caco2 cells | Homo sapiens | 15 | ALA2396517 | cell-based format | Scientific Literature | |
19. | ALA2399059 | P | Lipophilicity, log D of the compound at pH 7.4 | 15 | ALA2396517 | small-molecule physicochemical format | Scientific Literature | ||
20. | ALA2399060 | P | Solubility of the compound at pH 6.8 | 15 | ALA2396517 | small-molecule physicochemical format | Scientific Literature |